CN103191385B - Medicament for treating infantile asthma - Google Patents

Medicament for treating infantile asthma Download PDF

Info

Publication number
CN103191385B
CN103191385B CN201310108672.XA CN201310108672A CN103191385B CN 103191385 B CN103191385 B CN 103191385B CN 201310108672 A CN201310108672 A CN 201310108672A CN 103191385 B CN103191385 B CN 103191385B
Authority
CN
China
Prior art keywords
parts
herba
radix
folium
fructus
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN201310108672.XA
Other languages
Chinese (zh)
Other versions
CN103191385A (en
Inventor
孟令鲁
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Meng Linglu
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN201310108672.XA priority Critical patent/CN103191385B/en
Publication of CN103191385A publication Critical patent/CN103191385A/en
Application granted granted Critical
Publication of CN103191385B publication Critical patent/CN103191385B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)
  • Medicinal Preparation (AREA)

Abstract

The invention relates to a medicament for treating infantile asthma. The medicament is prepared from the following materials in parts by weight: 5 to 10 parts of figwort, 10 to 20 parts of dried ginger, 20 to 30 parts of dogwood, 10 to 20 parts of platycodon grandiflorum, 15 to 25 parts of coptis, 5 to 15 parts of chrysanthemum, 10 to 30 parts of solidago, 1 to 15 parts of henbane, 10 to 20 parts of ephedra, 15 to 30 parts of pyrrosia, 20 to 30 parts of tabasheer, 1 to 20 parts of morinda officinalis, 1 to 20 parts of weeping forsythia, 10 to 25 parts of China rose, 10 to 30 parts of pseudo-ginseng, 1 to 20 parts of emblic leafflower fruit, 15 to 20 parts of murraya paniculata, 10 to 20 parts of semen pharbitidis, 15 to 20 parts of inula herb, 15 to 30 parts of glabrous sarcandra herb, 10 to 20 parts of clinopodium polycephalum, 10 to 25 parts of senna leaf, 5 to 15 parts of aleppo avens, 1 to 20 parts of uniflower swisscentaury root, 15 to 25 parts of dahurian rhododendron leaf, 15 to 25 parts of potentilla discolor, 10 to 20 parts of physalis permviana, 15 to 25 parts of root bark of white mulberry, 20 to 30 parts of lindley eupatorium herb, 1 to 20 parts of glossy privet fruit and 10 to 25 parts of folium isatidis. All components of the medicament for treating the infantile asthma are natural materials, so the medicament is high in safety, definite in treatment effect and suitable to be clinically popularized in a large scale.

Description

A kind of medicament for the treatment of infantile asthma
Technical field
The present invention relates to field of medicaments, relate in particular to a kind of medicament for the treatment of infantile asthma.
Background technology
Infantile asthma is the common chronic respiratory tract disease of child.Its sickness rate is worldwide in rising trend in recent years, and the prevalence of developed country's childhood asthma is up to more than 10%.The average prevalence of Chinese children asthma in 2000 is 1.97%, has risen 64.8% than nineteen ninety.Due to asthma Chang Fanfu outbreak, be difficult to radical cure, so have a strong impact on the physical and mental health of infant, also bring heavy financial burden and stress to infants ' parents.Also be the emphasis during child works for the control of infantile asthma at present.
Summary of the invention
The object of this invention is to provide a kind of medicament for the treatment of infantile asthma.
In order to realize object of the present invention, the invention provides a kind of medicament for the treatment of infantile asthma, it is to be made up of the material of following weight proportioning: Radix Scrophulariae 5-10 part, Rhizoma Zingiberis 10-20 part, Fructus Corni 20-30 part, Radix Platycodonis 10-20 part, Rhizoma Coptidis 15-25 part, Flos Chrysanthemi 5-15 part, Herba Solidaginis 10-30 part, Semen Hyoscyami 1-15 part, Herba Ephedrae 10-20 part, Folium Pyrrosiae 15-30 part, Concretio Silicea Bambusae 20-30 part, Radix Morindae Officinalis 1-20 part, Fructus Forsythiae 1-20 part, Flos Rosae Chinensis 10-25 part, Radix Notoginseng 10-30 part, Fructus Phyllanthi 1-20 part, Folium Et Cacumen Murrayae 15-20 part, Semen Pharbitidis 10-20 part, Herba Inulae 15-20 part, Herba Sarcandrae 15-30 part, Herba Clinopodii 10-20 part, Folium Sennae 10-25 part, Radix seu Herba Gei aleppici 5-15 part, Radix Rhapontici 1-20 part, Folium Rhododendri Daurici 15-25 part, Herba Potentillae Discoloris 15-25 part, Calyx Seu Fructus Physalis 10-20 part, Cortex Mori 15-25 part, Herba Eupatorii Lindleyani 20-30 part, Fructus Ligustri Lucidi 1-20 part and Folium Isatidis 10-25 part.
Preferably, the medicament for the treatment of infantile asthma of the present invention is to be made up of the material of following weight proportioning: 7 parts of Radix Scrophulariaes, 13 parts of Rhizoma Zingiberiss, 22 parts of Fructus Corni, 15 parts of Radix Platycodoniss, 21 parts of Rhizoma Coptidis, 13 parts of Flos Chrysanthemis, 28 parts of Herba Solidaginiss, 11 parts of Semen Hyoscyamis, 17 parts, Herba Ephedrae, 24 parts of Folium Pyrrosiaes, 27 parts of Concretio Silicea Bambusaes, 18 parts of Radix Morindae Officinaliss, 17 parts of Fructus Forsythiaes, 23 parts of Flos Rosae Chinensiss, 21 parts of Radix Notoginseng, 16 parts of Fructus Phyllanthis, 16 parts of Folium Et Cacumen Murrayae, 17 parts of Semen Pharbitidiss, 19 parts of Herba Inulae, 15 parts of Herba Sarcandraes, 14 parts of Herba Clinopodii, 21 parts of Folium Sennae, 11 parts of Radix seu Herba Gei aleppici, 13 parts of Radix Rhapontici, 23 parts of Folium Rhododendri Daurici, 24 parts of Herba Potentillae Discoloris, 14 parts of Calyx Seu Fructus Physaliss, 25 parts of Cortex Mori, 26 parts of Herba Eupatorii Lindleyanis, 24 parts of 16 parts of Fructus Ligustri Lucidi and Folium Isatidiss.
More preferably, described medicament can be tablet, dispersible tablet, capsule or decoction.
Whole compositions of the medicament for the treatment of infantile asthma of the present invention are all natural materials, and safety is better, and curative effect is clear and definite, are suitable for large-scale promotion clinically.
Detailed description of the invention
Further illustrate the present invention below by embodiment.It should be understood that embodiments of the invention are for the present invention instead of limitation of the present invention are described.The simple modifications that essence according to the present invention is carried out the present invention all belongs to the scope of protection of present invention.Except as otherwise noted, the percent otherwise in the present invention is percetage by weight.
Embodiment decoction of the present invention
Take 7 grams of Radix Scrophulariaes, 13 grams of Rhizoma Zingiberiss, 22 grams of Fructus Corni, 15 grams of Radix Platycodoniss, 21 grams of Rhizoma Coptidis, 13 grams of Flos Chrysanthemis, 28 grams of Herba Solidaginiss, 11 grams of Semen Hyoscyamis, 17 grams, Herba Ephedrae, 24 grams of Folium Pyrrosiaes, 27 grams of Concretio Silicea Bambusaes, 18 grams of Radix Morindae Officinaliss, 17 grams of Fructus Forsythiaes, 23 grams of Flos Rosae Chinensiss, 21 grams of Radix Notoginseng, 16 grams of Fructus Phyllanthis, 16 grams of Folium Et Cacumen Murrayae, 17 grams of Semen Pharbitidiss, 19 grams of Herba Inulae, 15 grams of Herba Sarcandraes, 14 grams of Herba Clinopodii, 21 grams of Folium Sennae, 11 grams of Radix seu Herba Gei aleppici, 13 grams of Radix Rhapontici, 23 grams of Folium Rhododendri Daurici, 24 grams of Herba Potentillae Discoloris, 14 grams of Calyx Seu Fructus Physaliss, 25 grams of Cortex Mori, 26 grams of Herba Eupatorii Lindleyanis, 24 grams of 16 grams of Fructus Ligustri Lucidi and Folium Isatidiss, add 2000 milliliters, water, in the flask that condensing tube is housed, at 80 DEG C, heat 4 hours, filter.Filtrate is concentrated into 600 milliliters, obtains decoction of the present invention.
Experimental example
Diagnostic criteria
The cough variant asthma diagnostic criteria of formulating according to national pediatric asthma cooperative groups in 1998 (national pediatric asthma control association group. pediatric asthma control routine (trying). Pediatrics magazine, 1998,36 (12); 747.) judge: cough continues or repeatedly shows effect assorted 30 days, often accompanies the ictal cough of night or early morning, and expectorant is few, and motion increases the weight of; Clinical invalid without infection sign or long-term antibiotic therapy; With bronchodilator can make coughing fit alleviate; Except the chronic cough that causes of other reasons; A guy or family's allergies, measurement of bronchial responsiveness, allergen detection etc. can be made auxiliary diagnosis.
20 routine infants, wherein male 10 examples, female's 10 examples, reckling 2 years old, the maximum 5 years old.
Therapeutic Method:
Use the decoction of preparing in embodiment, take each 30 milliliters every day 2 times.It within one week, is 1 course for the treatment of.
Curative effect determinate standard:
The criterion of therapeutical effect formulated according to Department of Medical Administration of State Administration of Traditional Chinese Medicine (Department of Medical Administration of State Administration of Traditional Chinese Medicine. the inside and outside Gynecology & Pediatrics Dept. disease Standardization of diagnosis and curative effect of the traditional Chinese medical science. Nanjing: Jiangsu science tech publishing house, 1998,136.): clinical cure: cough and pharyngeal transference cure, more than 2 weeks do not send out again; Take a turn for the better: symptom alleviates; Invalid: symptom is not improved.
Therapeutic outcome:
Treating after the course for the treatment of, whole 20 routine patients all cure.

Claims (2)

1. treat the medicament of infantile asthma for one kind, it is characterized in that, it is to be made up of the material of following weight proportioning: Radix Scrophulariae 5-10 part, Rhizoma Zingiberis 10-20 part, Fructus Corni 20-30 part, Radix Platycodonis 10-20 part, Rhizoma Coptidis 15-25 part, Flos Chrysanthemi 5-15 part, Herba Solidaginis 10-30 part, Semen Hyoscyami 1-15 part, Herba Ephedrae 10-20 part, Folium Pyrrosiae 15-30 part, Concretio Silicea Bambusae 20-30 part, Radix Morindae Officinalis 1-20 part, Fructus Forsythiae 1-20 part, Flos Rosae Chinensis 10-25 part, Radix Notoginseng 10-30 part, Fructus Phyllanthi 1-20 part, Folium Et Cacumen Murrayae 15-20 part, Semen Pharbitidis 10-20 part, Herba Inulae 15-20 part, Herba Sarcandrae 15-30 part, Herba Clinopodii 10-20 part, Folium Sennae 10-25 part, Radix seu Herba Gei aleppici 5-15 part, Radix Rhapontici 1-20 part, Folium Rhododendri Daurici 15-25 part, Herba Potentillae Discoloris 15-25 part, Calyx Seu Fructus Physalis 10-20 part, Cortex Mori 15-25 part, Herba Eupatorii Lindleyani 20-30 part, Fructus Ligustri Lucidi 1-20 part and Folium Isatidis 10-25 part.
2. the medicament for the treatment of infantile asthma according to claim 1, it is characterized in that, it is to be made up of the material of following weight proportioning: 7 parts of Radix Scrophulariaes, 13 parts of Rhizoma Zingiberiss, 22 parts of Fructus Corni, 15 parts of Radix Platycodoniss, 21 parts of Rhizoma Coptidis, 13 parts of Flos Chrysanthemis, 28 parts of Herba Solidaginiss, 11 parts of Semen Hyoscyamis, 17 parts, Herba Ephedrae, 24 parts of Folium Pyrrosiaes, 27 parts of Concretio Silicea Bambusaes, 18 parts of Radix Morindae Officinaliss, 17 parts of Fructus Forsythiaes, 23 parts of Flos Rosae Chinensiss, 21 parts of Radix Notoginseng, 16 parts of Fructus Phyllanthis, 16 parts of Folium Et Cacumen Murrayae, 17 parts of Semen Pharbitidiss, 19 parts of Herba Inulae, 15 parts of Herba Sarcandraes, 14 parts of Herba Clinopodii, 21 parts of Folium Sennae, 11 parts of Radix seu Herba Gei aleppici, 13 parts of Radix Rhapontici, 23 parts of Folium Rhododendri Daurici, 24 parts of Herba Potentillae Discoloris, 14 parts of Calyx Seu Fructus Physaliss, 25 parts of Cortex Mori, 26 parts of Herba Eupatorii Lindleyanis, 24 parts of 16 parts of Fructus Ligustri Lucidi and Folium Isatidiss.
CN201310108672.XA 2013-03-22 2013-03-22 Medicament for treating infantile asthma Expired - Fee Related CN103191385B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201310108672.XA CN103191385B (en) 2013-03-22 2013-03-22 Medicament for treating infantile asthma

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201310108672.XA CN103191385B (en) 2013-03-22 2013-03-22 Medicament for treating infantile asthma

Publications (2)

Publication Number Publication Date
CN103191385A CN103191385A (en) 2013-07-10
CN103191385B true CN103191385B (en) 2014-06-04

Family

ID=48714318

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201310108672.XA Expired - Fee Related CN103191385B (en) 2013-03-22 2013-03-22 Medicament for treating infantile asthma

Country Status (1)

Country Link
CN (1) CN103191385B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103550545B (en) * 2013-10-23 2016-01-20 朱军 A kind of Chinese medicine for the treatment of cardiac asthma
CN103550459B (en) * 2013-11-05 2015-09-16 史秀华 A kind of preparation method for the treatment of the medicament of infantile asthma

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101028507A (en) * 2007-02-26 2007-09-05 赵红霞 Chinese-medicinal composition for treating asthma
CN101708303A (en) * 2009-12-14 2010-05-19 陈玲 Chinese medicinal composition for treating asthma
CN102526674A (en) * 2012-02-06 2012-07-04 孟庆云 Medicine for treating bronchitis and bronchial asthma suffered by children aging from three to seven
CN102580047A (en) * 2012-03-23 2012-07-18 刘香莉 Chinese medicinal pills for treating kidney-deficiency asthma

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101028507A (en) * 2007-02-26 2007-09-05 赵红霞 Chinese-medicinal composition for treating asthma
CN101708303A (en) * 2009-12-14 2010-05-19 陈玲 Chinese medicinal composition for treating asthma
CN102526674A (en) * 2012-02-06 2012-07-04 孟庆云 Medicine for treating bronchitis and bronchial asthma suffered by children aging from three to seven
CN102580047A (en) * 2012-03-23 2012-07-18 刘香莉 Chinese medicinal pills for treating kidney-deficiency asthma

Also Published As

Publication number Publication date
CN103191385A (en) 2013-07-10

Similar Documents

Publication Publication Date Title
CN101690745B (en) Chinese medicinal composition for preventing and treating flu
CN102357154A (en) Traditional Chinese medicine composition for preventing and treating avian infectious bronchitis and preparation method thereof
CN102488778A (en) Chinese traditional medicine preparation for treating upper respiratory tract infection of livestock and preparation method thereof
CN111317798A (en) Traditional Chinese medicine composition for detoxifying, eliminating dampness and relieving sore throat and application thereof
CN101559186B (en) Pharmaceutical composition for treating pulmonary tuberculosis, pneumonia and bronchitis
CN103191385B (en) Medicament for treating infantile asthma
CN116139237B (en) A Chinese medicinal composition for preventing and treating respiratory tract infection caused by coronavirus, and its application
CN103142982A (en) Medicine for treating acute upper respiratory infection
CN103142959A (en) Medicament for treating urticaria
CN103142987B (en) Medicament for treating mumps
CN102139051A (en) Application of soft capsule capable of clearing heat and eliminating toxin in preparation of medicament for treating viral pneumonia
CN103405722B (en) Chinese herba preparation for preventing and treating infantile cough
CN102429979A (en) Traditional Chinese medicine composition for treating cold and preparation method thereof
CN103877385A (en) Medicine composition for treating herpangina
CN103142954A (en) Medicine for treating asthma
CN103550516B (en) A kind of preparation method for the treatment of the medicament of perianal abscess
CN103157089A (en) Medicament for treating infantile diarrhea
CN103520386B (en) Preparation method of medicine composition used for treating children asthma
CN102488788B (en) Medicinal composition for treating asthma in children
CN102429946B (en) Chinese medicinal composition for preparing anti-influenza virus medicament
CN100457177C (en) Chinese medicinal health-care preparation for cloaring lung, supplementing kidney
CN104547575A (en) Traditional Chinese medicinal composition for treating capillary bronchitis and induced diarrhea and method for preparing composition
CN105288202A (en) Pharmaceutical composition for curing infantile cough
CN103142980A (en) Medicament for treating infantile cough
CN103142977A (en) Medicament for treating dysmenorrhea

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
ASS Succession or assignment of patent right

Owner name: MENG LINGLU

Free format text: FORMER OWNER: ZHANG XIAOQIAN

Effective date: 20140505

C41 Transfer of patent application or patent right or utility model
C53 Correction of patent for invention or patent application
CB03 Change of inventor or designer information

Inventor after: Meng Linglu

Inventor before: Zhang Xiaoqian

COR Change of bibliographic data

Free format text: CORRECT: INVENTOR; FROM: ZHANG XIAOQIAN TO: MENG LINGLU

Free format text: CORRECT: ADDRESS; FROM: 272699 JINING, SHANDONG PROVINCE TO: 272025 JINING, SHANDONG PROVINCE

TA01 Transfer of patent application right

Effective date of registration: 20140505

Address after: Supply road 272025 in Shandong province Jining City No. 12 Jining Maternal and Child Health-Care Hospital Department of child health care

Applicant after: Meng Linglu

Address before: Shuibo 272699 Shandong County of Liangshan Province Road No. 82

Applicant before: Zhang Xiaoqian

C14 Grant of patent or utility model
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20140604

Termination date: 20150322

EXPY Termination of patent right or utility model